Insider trading

Period: 120 months Stock: LLY Type of trade: Bought × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Aug 2025
Montarce Lucas EVP & CFO
Bought
$494.63K 715 at 691.79
5.1%
First buy on file
13 Aug 2025
Van Naarden Jacob EVP & Pres., Lilly Oncology
Bought
$647.36K 1,000 at 647.36
5.1%
First buy on file
13 Aug 2025
Alvarez Ralph Director · indirect
Bought
$500.47K 758 at 660.25
opened
First buy on file
12 Aug 2025
Ricks David A President, Chair, and CEO
Bought
$1.05M 1,632 at 644.77
0.3%
First buy on file
12 Aug 2025
Fyrwald J Erik Director
Bought 2×
$1.01M 1,565 at 642.33
2.1%
First buy on file
12 Aug 2025
Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm
Bought
$634.41K 1,000 at 634.41
0.7%
First buy on file
12 Aug 2025
Bought
$75.02K 117 at 641.18
4.5%
First buy on file
8 Aug 2025
JACKSON JAMERE Director
Bought
$127.91K 200 at 639.56
2.2%
First buy on file
12 Aug 2022
TAI JACKSON P Director
Bought
$199.55K 656 at 304.19
1.1%
1 Mar 2022
Bought
$49.85K 202 at 246.78
1.3%
First buy on file
30 Apr 2021
TAI JACKSON P Director
Bought 2×
$249.76K 1,366 at 182.84
2.3%
First buy on file
25 Oct 2019
Skovronsky Daniel SVP, CSO, and Pres. LRL
Bought
$543.05K 5,000 at 108.61
7.1%
First buy on file
25 Oct 2019
Ricks David A President & CEO
Bought
$500.17K 4,615 at 108.38
3.0%
First buy on file
25 Oct 2019
White Anne E. SVP & Pres-Lilly Oncology
Bought
$108.84K 1,000 at 108.84
4.8%
First buy on file
25 Oct 2019
Smiley Joshua L SVP and CFO
Bought
$99.95K 929 at 107.59
3.0%
First buy on file
24 Oct 2019
TAI JACKSON P Director
Bought
$200.04K 1,861 at 107.49
3.4%
First buy on file
15 Jul 2019
Smiley Joshua L SVP and CFO
Bought
$20.07K 185 at 108.47
0.6%
First buy on file
5 Jun 2019
Smiley Joshua L SVP and CFO
Bought
$50.28K 426 at 118.03
1.4%
First buy on file
26 Jul 2018
TAI JACKSON P Director
Bought
$206.44K 2,168 at 95.22
4.2%
First buy on file
14 Jun 2018
Skovronsky Daniel SVP, CSO, and Pres. LRL
Bought
$862.20K 10,000 at 86.22
22.1%
First buy on file
16 Dec 2016
TAI JACKSON P Director
Bought
$99.88K 1,375 at 72.64
2.9%
First buy on file
16 Dec 2016
HOOVER R DAVID Director · indirect
Bought
$35.93K 500 at 71.85
50.0%
First buy on file
Showing 1–22 of 22.